Address
304 North Cardinal
St. Dorchester Center, MA 02124
Work Hours
Monday to Friday: 7AM - 7PM
Weekend: 10AM - 5PM
Address
304 North Cardinal
St. Dorchester Center, MA 02124
Work Hours
Monday to Friday: 7AM - 7PM
Weekend: 10AM - 5PM

$179.00
| Brand | Aspen Health |
| Product | GLP-1 Weight Loss Program |
| Type | Prescription Telehealth Medical Weight Loss Program |
| Form | Subcutaneous Injectable Solution (pre-filled pens or multi-dose vials with sterile syringes, determined by prescription) |
| Quantity | 30-day supply per fulfillment (with ongoing periodic renewals) |
| Ingredients | Active pharmaceutical ingredients prescribed per patient: Semaglutide or Tirzepatide (compounded preparations may include Vitamin B12/Cyanocobalamin or Glycine depending on compounding pharmacy formulation). |
| Suggested Use | Subcutaneous self-injection once weekly into the abdomen, thigh, or upper arm, following a personalized clinical titration schedule. |
| Manufacturer | Aspen Health (dispensed via licensed partner 503A / 503B compounding and retail pharmacies) |
| Country of Origin | United States |
The Aspen Health GLP-1 Weight Loss Program is a clinical, physician-managed telehealth service created to provide accessible, medically supervised care for individuals seeking sustainable weight management. Rather than relying on non-prescription supplements or restrictive short-term diets, Aspen Health pairs patients directly with licensed healthcare providers to evaluate their metabolic profile and determine whether prescription GLP-1 (glucagon-like peptide-1) or dual GIP/GLP-1 receptor agonists are clinically appropriate.
The program includes the initial medical evaluation, prescription fulfillment through accredited U.S. partner pharmacies, home delivery of all necessary injection supplies, and regular dosage adjustments to optimize tolerability and effectiveness over time.
Clinically Supervised Appetite Regulation: Designed to assist with natural appetite suppression and portion control by targeting hunger-signaling pathways in the brain.
Prolonged Satiety: Helps delay stomach emptying, allowing you to feel satisfied longer after smaller, balanced meals.
Personalized Care & Titration: Treatment begins at a low introductory dose to help your digestive system adjust smoothly, gradually titrating under provider direction.
Convenient Home Administration: Eliminates monthly in-clinic visits through an entirely virtual, secure telehealth platform and door-to-door delivery.
Metabolic Support: Supports baseline insulin sensitivity and steady blood glucose management when paired with a calorie-reduced diet and increased physical activity.
Aspen Health provides access to prescription therapies tailored to each patient’s clinical evaluation. Formulations depend on the specific medication authorized by your provider:
Semaglutide (GLP-1 Receptor Agonist): A synthetic peptide that mimics endogenous glucagon-like peptide-1, supporting appetite suppression, glycemic control, and delayed gastric emptying.
Tirzepatide (GIP / GLP-1 Dual Receptor Agonist): A dual-action peptide targeting both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors to promote satiety and metabolic response.
Formulation Additives (Compounded Variants): Certain compounding pharmacy preparations may incorporate Vitamin B12 (Cyanocobalamin) or L-Carnitine to support cellular energy production and help mitigate treatment-associated nausea.
Supplies Included: Alcohol prep pads, sterile single-use insulin syringes (or auto-injector pen needles), and patient instructions.
GLP-1 receptor agonists function by mimicking the physiological action of the GLP-1 incretin hormone naturally secreted by the intestines following food intake:
Neural Appetite Signaling: Active compounds bind to GLP-1 receptors in the hypothalamus, promoting satiety and attenuating persistent food cravings.
Gastric Motility Modulation: Slows the rate at which food empties from the stomach into the small intestine, extending feelings of fullness between meals.
Glucoregulatory Balance: Stimulates glucose-dependent insulin secretion from pancreatic beta cells while suppressing inappropriate postprandial glucagon release, contributing to balanced blood sugar levels.
Administration: Administered via subcutaneous injection into the fatty tissue of the abdomen, front of the thigh, or upper outer arm. Rotate the injection site each week.
Frequency & Timing: Administer once every 7 days, on the same day each week, at any time of day, with or without food.
Dosage Schedule: Strictly follow the titration schedule prescribed by your Aspen Health clinician. Treatment typically starts at a low introductory dose (e.g., Semaglutide 0.25 mg weekly) for the first 4 weeks, with progressive increases based on individual tolerance and therapeutic response.
Storage Instructions: Store unopened vials/pens in the refrigerator between 36°F and 46°F (2°C to 8°C). Do not freeze. Protect from direct heat and light. Keep out of reach of children.
The Aspen Health GLP-1 Weight Loss Program is intended for adult individuals (aged 18 and older) who meet clinical criteria for medical weight management, including:
Adults with a Body Mass Index (BMI) of 30 kg/m² or greater.
Adults with a BMI of 27 kg/m² or greater accompanied by at least one weight-related comorbidity (e.g., hypertension, dyslipidemia, or insulin resistance).
Individuals who have struggled to achieve sustained weight loss through dietary and lifestyle modifications alone and seek doctor-supervised clinical treatment.
Do not use this program or GLP-1 medications if you:
Have a personal or family history of Medullary Thyroid Carcinoma (MTC).
Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Have had a serious hypersensitivity or allergic reaction to Semaglutide, Tirzepatide, or any product excipients.
Are currently pregnant, planning to become pregnant, or breastfeeding.
Have a history of pancreatitis, active gallbladder disease, or severe gastroparesis.
Are under 18 years of age.
Prescription Requirement: This program requires an asynchronous or live telehealth medical consultation. Submitting an order does not guarantee a prescription; treatment is provided solely at the medical discretion of a licensed healthcare practitioner.
Potential Side Effects: The most common adverse effects are gastrointestinal and typically mild-to-moderate, including nausea, diarrhea, vomiting, constipation, abdominal discomfort, and acid reflux. These effects most frequently occur during initial dosing or dosage escalation.
Hydration & Nutrition: Adequate fluid intake is recommended throughout treatment to prevent dehydration and support renal function.
Black Box Warning: GLP-1 receptor agonists carry a boxed warning regarding the potential risk of thyroid C-cell tumors based on rodent studies. Consult your prescribing clinician immediately if you experience a neck mass, hoarseness, or difficulty swallowing.
Doctor-Led Protocol: Aspen Health removes the guesswork by connecting you directly with qualified medical providers who oversee your dosing, check your progress, and adjust your treatment plan.
Transparent, Predictable Access: Transparent pricing models without hidden pharmacy dispensing fees or retail markups.
Comprehensive Home Delivery: Medications arrive cold-packed at your doorstep with clear administration instructions, injection supplies, and disposal guidance.
Tailored Titration Steps: Care plans are structured around gradual titration to minimize digestive discomfort and build sustainable, long-term habits.
Convenient Ongoing Check-Ins: Secure digital messaging lets you report progress, discuss tolerability, and renew your prescription without sitting in a waiting room.
What is the Aspen Health GLP-1 Weight Loss Program?
It is a virtual, doctor-supervised weight loss service that provides eligible patients with clinical evaluations, personalized prescriptions for GLP-1 medications, ongoing medical oversight, and home medication delivery.
Do I need a prior prescription from my regular doctor?
No. Your initial health assessment and medical evaluation are conducted online through Aspen Health’s licensed healthcare network, which issues the prescription if you meet clinical criteria.
How is the medication taken?
GLP-1 medications like Semaglutide and Tirzepatide are self-administered once per week via a subcutaneous injection using a micro-needle into the abdomen, thigh, or upper arm.
What active ingredients are used?
Depending on your clinical eligibility and provider selection, treatments utilize active GLP-1 receptor agonists such as Semaglutide or dual GIP/GLP-1 agonists such as Tirzepatide. Compounded preparations may also include additives like Vitamin B12.
How quickly does the medication ship?
Once your online intake is completed and a provider approves your treatment, orders are sent to a partner pharmacy for compounding or dispensing, typically arriving in temperature-controlled packaging within 3 to 7 business days.
Can I cancel or pause my program?
Yes. Aspen Health allows patients to manage their program, review renewal cadences, and pause or adjust treatments directly through their patient account or with customer support prior to pharmacy fulfillment.
The Aspen Health GLP-1 Weight Loss Program bridges the gap between clinical efficacy and modern telehealth convenience. By combining physician oversight, tailored dosage escalations, and reliable home delivery of GLP-1 medications, it offers a structured medical pathway for adults seeking sustainable weight management under professional supervision.179+